Search results
Novartis (NVS) Plans to Spin Off Generics Business Sandoz
Zacks via Yahoo Finance· 2 years agoNovartis NVS has announced plans to spin off Sandoz, its generics and biosimilars division, into a...
Novartis (NVS) Q3 Earnings Top, Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoNovartis AG NVS reported mixed third-quarter results for 2022 and revised its guidance for the...
Top Analyst Reports for Novartis, Duke Energy & Boston Scientific
Zacks via Yahoo Finance· 2 years agoToday's Research Daily features new research reports on 16 major stocks, including Novartis AG...
The Zacks Analyst Blog Highlights Bank of America, Novo Nordisk, Novartis, Analog Devices and Sony...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – May 25, 2022 – Zacks.com announces the list of stocks featured...
How the Pharmaceutical Industry Is Using AI
ETF Trends via Yahoo Finance· 12 months agoIndustry-leading pharmaceutical firms are adopting artificial intelligence (AI) to drive value for the future of their enterprise. AI is currently being...
Asthma Medication May Help Children with Severe Allergies Safely Eat Nuts and Other Foods
People via Yahoo News· 4 months agoA new study shows that Xolair, commonly used to treat asthma and hives, may allow children with...
Incyte (INCY) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoIncyte Corporation INCY is scheduled to release its third-quarter 2022 results on Nov 1, before...
Why life-saving organ transplant drug was in short supply
The Hill via Yahoo News· 1 year agoStory at a glance Neoral is an immunosuppressant commonly used to prevent organ rejection after a...
Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 hours agoIncyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript April 30, 2024 Incyte Corporation...
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 1 day agoIncyte Corporation INCY reported first-quarter 2024 adjusted earnings of 64 cents per share, which...
